Large-cap Health Care company Centene has logged a -0.9% change today on a trading volume of 137,239. The average volume for the stock is 3,386,039.
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. Based in Saint Louis, United States the company has 74,300 full time employees and a market cap of $37,883,490,304.
The company is now trading -14.49% away from its average analyst target price of $81.82 per share. The 17 analysts following the stock have set target prices ranging from $71.0 to $110.0, and on average give Centene a rating of buy.
Over the last 12 months CNC shares have declined by -9.0%, which represents a difference of -28.0% when compared to the S&P 500. The stock's 52 week high is $87.84 per share and its 52 week low is $60.83. With its net margins declining an average -13.6% over the last 6 years, Centene declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-21 | 144,547,000 | 1,202,000 | 1 | 0.0 |
| 2022-02-22 | 125,982,000 | 1,347,000 | 1 | -50.0 |
| 2021-02-22 | 111,115,000 | 1,808,000 | 2 | 0.0 |
| 2020-02-18 | 74,639,000 | 1,321,000 | 2 | 100.0 |
| 2019-02-19 | 60,116,000 | 900,000 | 1 | -50.0 |
| 2018-02-20 | 48,382,000 | 828,000 | 2 |
